Chemoinformaics analysis of 2-Aminobutyric acid
| Molecular Weight | 103.121 | nRot | 2 |
| Heavy Atom Molecular Weight | 94.049 | nRig | 2 |
| Exact Molecular Weight | 103.063 | nRing | 0 |
| Solubility: LogS | -4.572 | nHRing | 0 |
| Solubility: LogP | 6.43 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 15.3851 |
| nHD | 2 | BPOL | 9.32686 |
| QED | 0.208 |
| Synth | 2.766 |
| Natural Product Likeliness | 1.068 |
| NR-PPAR-gamma | 0.8 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.959 |
| HIA | 0.015 |
| CACO-2 | -4.746 |
| MDCK | 0.0000332 |
| BBB | 0.076 |
| PPB | 0.971934 |
| VDSS | 0.766 |
| FU | 0.0187703 |
| CYP1A2-inh | 0.537 |
| CYP1A2-sub | 0.155 |
| CYP2c19-inh | 0.28 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.374 |
| CYP2c9-sub | 0.914 |
| CYP2d6-inh | 0.019 |
| CYP2d6-sub | 0.064 |
| CYP3a4-inh | 0.587 |
| CYP3a4-sub | 0.058 |
| CL | 9.062 |
| T12 | 0.6 |
| hERG | 0.184 |
| Ames | 0.017 |
| ROA | 0.013 |
| SkinSen | 0.953 |
| Carcinogencity | 0.152 |
| EI | 0.114 |
| Respiratory | 0.197 |
| NR-Aromatase | 0.621 |
| Antiviral | No |
| Prediction | 0.959083 |